Skip to main content
Premium Trial:

Request an Annual Quote

Biotage to Change to Common Shares, Will Get New Ticker Symbol

NEW YORK (GenomeWeb News) – Biotage is shifting to publicly traded common shares that will trade under the new ticker symbol BIOT, the Swedish company said today.
 
Only common shares will be available for Biotage investors after March 29, when it changes out its A-shares to Ak securities without serial identification, the company said.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more